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1. INTRODUCTION 
The siddha system has its entire literature in Tamil language. This system of medicine 
was developed by the 18 ancient saints who were known by their name siddhars whose life goal 
was to attain the salvation. The siddha system of medicine uses a fascinating combination of 
herbs, minerals and metals and to promote good health and longevity
1
. According to siddha 
system, the universe originally consisted of atoms which contributed to the basic elements,viz., 
Earth, Water ,Fire ,Air and the Sky which correspond to the organs of the human body and they 
were the fundamentals of all the corporeal things in the world.    The history of siddha medicine 
is to present a faithful, clear , and vivid picture of this system in all its manifestations and 
ramifications with all its inherent problems and relevancy to the present age from its very 
beginning down the ages , as an integral component of the patterns of culture through which this 
system passed in different ages and in different areas, so that , this age can get to know of its 
uniqueness in several aspects                     
 Its  very clear and evident from long history of usage of  herbomineral and metallic 
preparations in Ayurveda and Siddha  medical system that properly processed herbomineral 
preparation can contribute significantly to the health care of the society. To understand the 
science involved in the purification processes a simple method was selected and studied. The 
common techniques used for the purification of a particular compound are based on its nature 
and also on the nature of the impurities present in it.        
Siddha medical system that properly processed herbomineral formulation can contribute 
significantly to the health care of the society 
2
.Siddha medicines are formulated based on the  
concept of “Panjabhootha theory” and “Arusuvaikal ” and on the basis of three humours  
(vatham, pitham, kabham). The prevalence of female infertility Number of married women aged 
15-44 that are infertile is 1.0 million. Number of women aged 15-44 who have ever used 
infertility services: 6.9 million. Globally, anaemia affects 1.62 billion people (95% CI: 1.50–1.74 
billion), which corresponds to 24.8% of the population (95% CI: 22.9–26.7%). The highest 
prevalence is in preschool-age children (47.4%, 95% CI: 45.7–49.1), and the lowest prevalence 
is in men (12.7%, 95% CI: 8.6–16.9%)(3). 
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 The prevalence of dysmenorrhea in adolescent girls was found to be 79.67%. However, 
the population group with the greatest number of individuals affected is non-pregnant women 
(468.4 million, 95% CI: 446.2–490.6). Because of the increased prevalence there is an 
emergence need of an effective drug for the management of female infertility, Dysmenorrhea, 
anaemia and other chronic diseases
(4)
.   
Palagarai chunnam is one of the traditional Siddha formulation which is indicated as a 
best drug for Female Infertility, Dysmenorrhea, Anemia, Dropsy in Siddha text Siddha 
maruthuva nool thirattu - Anubhava Siddha Vaithiya Muraigal. Scientific validation of this 
formulation Palagarai chunnam have to be studied and the safety of the drug have to be ensured.   
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                                              2. AIM AND OBJECTIVES 
 
 
    AIM 
            To evaluate the safety profile of (Acute and 28days Repeated dose oral 
Toxicity study) “Palagarai chunnam” in Wistar albino rats. 
    OBJECTIVE 
 Collect the literature  review of  ingredients of Palagarai chunnam 
 Purification and preparation of the Medicine as per literature 
 To Analyses the physical and chemical properties of “Palagarai chunnam”. 
 Acute oral toxicity study & 28days repeated oral toxicity study of Palagarai 
chunnam as per OECD Guideline 423 & 407. 
 Evaluation of  safety of the study drug  
  
 
 
 
. 
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1.gyfiw 
 
NtWngah; : ftb ,Nrhfp, tuhb
 
 
Rit : ifg;G 
 
nra;if : jhJntg;gfw;wp 
Nfhioafw;wp 
ntspgpuNahfj;jpy; jbg;Gz;lhf;fp 
 
epwk; : nts;is, kQ;rs;, rptg;G 
ntz;zpw gyfiwNa rpwe;jJ 
msT : Gspapd; tpj;J Kjy; thJik nfhl;il gUkd; 
 
 
nghJ Fzk;: 
 “ke;jje;jh fq;fpufzp  khtplr; Ruq;fz;Nzha; 
njhe;jk; gupehkr; #iyfa –  kpe;j 
Tyfiwiaf; fhnyhbit NahL eiuj;j 
gyfiwia fhzpdpak; ghu;”.
5 
 
 
gyfiw gw;gk;: 
xUgyk; Rj;jp nra;j gyfiwia vLj;J fPo; cs;s gl;bapy; Fwpj;j 
Kiwg;gb miuj;J cyu;j;jp Glk; ,lTk;. Xt;nthU ehSk; Fwpj;j Gjpa 
rhw;iw cgNahfpf;fTk;. tpy;iyia cyu;j;j #upa xspapy; itg;gJ Nghy 
,utpy; gdpapYk; itj;jy; Ntz;Lk;. 
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rhw ;w pd ; n ga u ; r hw ;w pd ; miuf;Fk; tpy;iy ftrk;  Glk;  
 msT e h s ; cyu;;j;Jk; cyu;j;Jk; ehs;  tul;b 
 gyk;  e h s ;    
       
 
RuGd;id r%yk; 4 6 5 1  36 
 
      
  
rpj;jpu%y r%yk; 4 5 4 1     30 
 
 fy;yhy; r%yk; 4  4  3 1 24 
         
fhl;Lky;ypif 3  3  2 1 18 
r%yk;         
         
ePNyhw;gy 2  2  1 1 12 
r%yk;         
         
re;jd Fok;G 1  1  1 1 6 
njspe Pu ;         
         
msT:         
fliyapy; 1:5  - cj;jkk;    
fliyapy; 2:5  - kj;jpkk;    
fliyapy; 3:5  - mjkk;    
fliyapy; 4:5  - mjkhjk;    
KOfliy  - Mde;jk;    
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jP&k; Neha;fs;: 
fg Neha; - mDghdk; -fs;    
gpj;j Neha ; - mDghdk;-nts;is rHf;fiu   
thj Neha; - mDghdk; -kfpok;G+ urk;   
 
 
gyfiw gw;g kfpik: 
,g;gw;gk; clypypUe;J ePq;fpa td;ikia jpUk;g nfhLj;J kfpo;it 
cz;L gz;Zk; 
 
gyfiw nre;Jhuk;: 
 
xU gyk; Rj;jp nra;j gyfiwg; nghbf;F fPo;f;fz;l gl;baypy; 
nfhLf;fg;gl;Ls;s Kiwg;gb rhWfis cgNahfpf;fTk;; 
1. khk;gl;il r%yr;rhW 
 
2. Midtzq;fp rhW 
 
3. tplj;Njhpr;rhW 
 
4. nrUg;gilr;rhW 
 
,itfis gw;gj;jpw;F $wpa mstpd; gb tpl;liuj;J tpy;iy 
nra;JyHj;jpf; ftrpj;J Glkpl;nlLf;f nre;Jhukhk;. 
 
msT: 2.5 (325kp.fp) Kjy; 5 Fd;wp (650 kp.fp) 
jPUk; Neha;fs;: ePnuhpr;ry; 
gpuNahfk;: 
,jid Gz;Zz;lhf;fp nra;iff;fhf cgNahfpg;gJz;L. 
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TREATMENT OF ANIMAL BITES WITH PALAGARAI PARPAM: 
Table no: 2 Therapeutic application of Palagarai Parpam as an anti - dote: 
S.no Name of the animal Adjuvant  
    
1 Dog   
 i)Natural rabies Juice of Curculigo orchoides (nilapanai) and  
  cow gram gruel.  
 ii)Induced rabies   Juice of banyan leaves and horsegram gruel  
 
    
2 Fox   
 i)Natural rabies Bamboo juice and dhal gruel  
 ii)Induced rabies Phyllanthus   amarus   (keezhanelli)   and  
  greengram gruel  
    
3 Cow   
 i)Natural rabies Betel leaves and little millet  
 ii)Induced rabies Achyranthus  aspera  (naayurivi)  and  kodo  
 
    
4 Buffalo   
 i)Natural rabies Nut grass and Italian millet  
 ii)Induced rabies Prosopis spicigera (vanni) juice with grass  
  seeds gruel  
    
5 Pig   
 i)Natural rabies Juice of bitter wild snake gourd and wheat  
  gruel  
 ii)Induced rabies Juice of bitter gourd and gruel of bamboo  
  sago  
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USAGE OF PALAGARAI PARPAM FOR VARIOUS TYPES OF WOUNDS AS 
OINTMENT 
5
 
 
 
1. Wounds caused by thorns and ox-horn -Apply with Parrot’s egg yolk 
2. Wounds caused by palm leaf stalk -Apply with Hen’s egg yolk 
3. Wounds caused due to knife, spear, etc -Apply with pigeon’s egg yolk 
4. Wounds caused by Stonning and bruise  
 caused by falling -Apply with Frog’s egg yolk 
5. Wounds caused due to ancient weapon  
 (gadhai), Stick and pestle -Apply with Crow’s egg yolk 
6. Wounds caused by striking with hands  
 and Pinching by nail - Apply with nightingale’s egg yolk 
7. Chronic wounds caused by various -Apply with Tortoise’s egg yolk 
 other means.  
6 Human   
 i)Natural rabies Juice of mollugo lotoides (cheruppadai) and 
 ii)Induced rabies  Creeper  juice  of  jackal  green  gram  and 
  lablab seed gruel 
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 gyfiw NrUk; kUe;Jfs;: 
 
 
 
 
 
 
 
      
 
 
    3. uj;jpdhjp khj;jpiu 
            msT : fLfsT 
            Kiw     : jha;g;ghypy; ,ioj;J ,U tpopfspypl Ntz;Lk; 
         jPUk; Neha;fs; : jpkpuk;, mkuk;, tpopfhrtif
6 
 
        4. rpNuh];jhd rpl;rpfhghprdk;  
          gyfiw  : 10 gyk;  
       MWkhj goq;fhb  : ehop (1.3 லி) 
        epk;g gor;rhW    : 6 gyk;  
       ,tw;iw fye;J itf;f Ntz;Lk;  
               Kiw   : erpak; fypf;fk;   
    
           nra;J gpd; 122 Flk; ePh; Cw;w Ntz;Lk; 
           jPUk; Neha;fs; : thjk;> gpj;jk;> igj;jpak; FzkhFk;
7
 
 
 
    
1.eadNuhfj;jpw;F khj;jpiu 
msT  : 1 khj;jpiu 
Kiw  : Kiyg;ghypy; ,ioj;J fz;zpypl Ntz;Lk; 
jPUk; Neha; : 20 tUlq;fs; nrd;w G+Tk; khWk;.
6 
2.ead tpahjpf;F khj;jpiu 
msT  : 1 khj;jpiu 
Kiw  : gps;isg; ghypy; ,ioj;J fz;zpypl Ntz;Lk; 
jPUk; Neha; : tpopNeha;fs; gyTk; jPUk;.
6
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        5 .fhJ rPo; nghq;Fjy;:  
           xU gyfiwia mLg;gpy; ed;wha; Rl;L ,bj;J Jhshf;fp xU 
    rpl;bif fhjpy; Nghl;L vYkpr;rk;go urk; nfhQ;rk; gpopaTk;
8
. 
 
       6. tp~;Z rf;fu khj;jpiu   
         msT : 1 Fd;wp  
      mDghdk; : jphpfLF Jhs;> ,Q;rp ePh;> Njd; 
         jPUk; Neha;fs; : gf;fthjk;> tpf;fy;> Nrhig> 13 rd;dp> Vg;gk;> 
                  %h;r;ir> thA
9
  
   
        7. fhu R+lrj;J gw;gk; 
            msT : 1- 1.5 gzntil  
         mDghdk; : ,sePh;> ntq;fha rhW> gourk;> Njd; 
         jPUk; Neha;fs; : ePuilg;G> fy;yilg;G> rijailg;G> ePh;f;fl;L 
           gj;jpak; : fhurhukw;w md;dk; nfhs;s Ntz;Lk;
10
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        1.1. PALAGARAI - Cypraea moneta 
 
Zoological classification 
11
:     
 
Kingdom : Animalia 
  
 
Phylum : Mollusca 
 
Order : Littorinimorpha 
 
Suborder : Cypraeoidea 
 
Family : Cypraeidae 
 
Genus : Cypraea 
 
Species : moneta
 
 
 
Vernacular names 
12
 : 
 
English : Porcelaneous shells, Marine shells, Money cowri, Cowri 
Sanskrit : Varatika, Varataka 
Arab : Sadaf                                           
Persian : Khar – Mahra 
Hindi : Cowri, Sipi                      
Bengali : Beya 
Gujarati : Codi 
Cannada : Kavdi 
Telugu : Gavalu 
Singalese : Pingo 
Tamil : Palagarai 
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General description 
Palagarai (Cypraea moneta) is known as the “Jewels of the sea”. Cyprea moneta is a very 
common species which is found widely in Indo-Pacific tropical waters. It is present in numerous 
regions, including East and South Africa, Madagascar, the Red Sea and the Persian Gulf, 
Maldives. 
Cowries have a dome shaped and almost hemispherical shell, shell, size varies from 8mm 
to 150mm, ovate to pyriform, highly enameled and have a smooth or occasionally pustulose 
surface. Aperture moderately narrow, and the labial and columellar lips are denticulate; Fossula 
may smooth or ribbed, extremities truncate or produced; Base of the shell convex or flat. Spires 
absent in the adult, Juvenile shell is strikingly different from that of an adult. A spiral shell is 
present in the early stage but on maturity the outer lip turns in, thickness and teeth develop on it 
and the inner lip(columella). The shell then turns ovate pyriform, domed, globular or 
hemispherical
12
. 
There is a pair of long, filiform cephalic tentacles bearing eyes at their outer bases .Foot is 
broad and extensible. Mantle cavity contains an arched ctenidium with several lamellae, a 
triradiate osphradium and a large hypo-branchial gland. Radula is long and taenioglossate(2-1-1-1-
2)..Sexes separate. Female lays eggs on coral substrate or in crevices of the reef. Egg mass is laid 
in either a circular or oblong shape and consist of layers of capsule in a cluster. Each egg mass 
with 100 to 300 eggs capsules. Egg capsules are various in colour like white, yellow, mauve or 
purple, orange, pink and each capsule with 200 to 500 eggs 
13. 
 “cowries” are inhabitant of coral reefs, and seek refuge from the sea under loose coral 
rocks, and hide in reef crevices and at the base of soft coral. Lives in warm waters of oceans. 
 
 
 
.  
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Worldwide dispersal of palagarai      
Cowries (Cypraea moneta) are represented by about 200 species in all but maximum 
numbers of about 140 species occur in the indo pacific region. Over 50 species are known from 
Indian seas. Greatest diversity seen the reef ward edge and surf beaten zones in coral reef eco 
system of Andaman and Nicobar Islands, Gulf of Mannar, gulf of kanchchh and Lakshadweep.  
Majority of the species inhabits shallow water, but a few may extend into the reef front that 
remains unexposed even during spring tide. The family is representing single genus, which is 
divided into more than 53 subgenera, some of which are elevated to a generic status by many 
authors 
13
. 
     
As our currency was used for a good 4,000 years, from the end of the 3rd century BC to the 
second half of the 20th century AD. The porcelain-like shell of the cowry circulated around the 
globe longer than any other currency in the history of money.  
The oldest written evidence of cowries being used as money was found in China. Evidence 
of the immense importance of the cowry in the history of Chinese coinage is the fact that our 
modern day symbol for money has its origin in the stylized image of a cowry. 
  The shell of the cowry, also known as “porcelains” in Old Italian, was highly coveted. Her 
Latin name Cypraea moneta indicates that the shell served as money for centuries. This cowry 
string is originally from Africa. 
           Cowries were exported to Africa since the 14th century, first by Arabic, then by English and 
even by German merchants. Today, the coins and banknotes of several states still refer to this 
ancient currency as this banknote from the Maldives shows. 
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Varieties: 
    Three varieties of cowries white, red and yellow are used in medicine. Ancient Alchemists 
preferred yellow colour. Cypraea moneta Linnaeus, 1758, is an abundant and easily recognized 
gastropod throughout the Indo-West pacific. A number of names distinguishing subspecies and 
races have been introduced for the money cowry, and it is generally recognized as a highly 
variable species. Different species of cowries are dependent on the 
 
                     Genetic factor 
 
 Pigmentation 
 
 Disease 
 
 Injury 
 
 Presence or absence of aluminum and other compounds 
 
 The acidity of the soil and water 
 
 Temperature of water. 
 
 
  Primarily genetic abnormalities, injury, disease and environmental factors can 
for instance lead to albinism, while certain diseases produce unusually large and heavy 
shells with a calloused, mottled appearance
14
. 
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Palagarai in astrology 
    A 'Kavadi' in Tamil stands for a sea shell. Using these, the position of an individual and the 
cause of his visit for consultation is found and the solution of his problems are suggested. For this, 
108 kavadis are used and they are rotated a number of times, the blessings of Guru are invoked.  
            A portion of the kavadis are separated and counted to find out the ruling planet at that time. 
The results of the prasna horoscope ( A horoscope formulated at the time of arrival of the persons) 
are compared with the results of the kavadi prasnam, and the predictions are pronounced
15
. 
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RECENT RESEARCHES ABOUT PALAGARAI: 
 
1. Cardiac activity and Analgesic activity 
          The presence of cardenolides contributes to the role of the deadly venoms of some cowrie 
shells which are used today to help victims of strokes, heart diseases and produce revolutionary 
new drug for chronic pain control
16
. 
2. Anti-inflammatory activity 
Powdered Pearls from shells are used as topical  Eye medicine. It has been scientifically 
proved to has some anti-inflammatory effect on conjunctivitis  where the surface of the eye 
become red and sore
17
. 
3. Antipyretic, anti - inflammatory, anti - microbial activity  
In the study, the efficacy of drug prepared from the shell of mollusk Cypraea moneta to 
reduce fever and heal wounds in albino rats as well as to inhibit microbial activity in vitro. This 
drug efficiently reduced the body temperature of rats that was made hyperthermia by yeast 
injection. Similarly, the wound healing process ending with the production of scar indicated that 
tissue regeneration was completed in drug administered rats. Sometimes pathogenic microbes can 
enter through the wound and produce pus. In this experiment, treated rats did not produce pus on 
the contrary to control rats. Thus Cypraea moneta is found to be effective in anti-pyretic, anti-
inflammatory, anti-microbial in experimentally induced albino rats.
18 
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2.CITRUS LEMON 
 
 
 
 
 
 
BOTANICAL CLASSIFICATION
13
 
 Kingdom  –  Plantae, Angiosperms, Eudicots, Rosids 
 Order   –  Sapindales 
 Family  –  Rutaceae 
 Genus  –  Citrus 
 Species  –  C.  limon 
 Binomial name -  Citrus × limon 
DIFFERENT NAME IN LEMON
14
 
 English: Lemon, Lime 
 Gujarat: Limbu, Motu limbu 
 Hindi: Nimbu 
 Kannadam: Nimbe 
 Malayalam: Cherunakaram 
 Tamil: Elumicahi 
 Telungu: Jambhira nimma  
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Description 
 Much branched thorny shrub leaves ovate, Petiole slightly winged. Flowers are white, 
axillary, solitary or clustered. Fruits oblong or ovoid, Bright yellow with terminal nipple, 
pericarp thick and seeds many. 
Distribution  
Throughout India, Cultivated in plains and hills in area upto 1,200m elevation. 
Habit – cultivatd in India, the terminal in the C.P., Kumaon and Northern India. 
Varieties- Two kind of limes are found in the Indian market. The lemon though belonging to the 
same stock. 
Parts Used- Rind of the ripe fruits and expressed juice of the ripe fruits. 
Constituents- A pale yellow volatile oil derived on either by distillation or by simple expression 
from the fresh outer part of the pericarp or finely grated rind of the fruit. Lemon is richer in juice 
and citric acid than lime. The average amount of citric acid available from 100 c.c.pf lemon juice 
is 3-7 percent. 
Action: 
 Stomachic and carminative 
Oil:   
 It is bitter, aromatic, stomachic and carminative n doses of from 2 to 4 drops but is rarely 
employed in this form. 
Juice: 
 The expressed strained juice of the ripe fruit is a valuable antiscorbutic and refrigerant , 
primarily anti alkaline and secondarily antacid .  
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Bark:  
 It is used as febrifuge and seeds as a vermifuge. Pulp is exceedingly acid 
 
Medicinal Uses of Lemon Juice 
 Lemon Juice and gun powder is applied topically for scabies.  
 Juice of the baked lemon is an excellent remedy for cough when mixed with an equal 
quantity of sugar or honey and taken in tea spoonful doses.  
 Fresh lemon juice is recommended to be taken in the evening for the relief of dyspepsia 
with vomiting and bilious headaches.  
 Preserved with sugar or honey lemons are recommended for sore throat and are 
considered to act as detergent they are administered before purgatives to prepare the body 
for them and afterwards to check excessive action.  
  Lemon plays an important part in perfumery also. The quality of Indian lemon peel is 
almost equal to the Sicilian variety and it has been estimated that if extraction of lemon 
oil is attempted from the Indian lemon Peel, It will not be a failure commercially
15
.  
 The fruits in the form of pickles is useful in hypertrophy of spleen.. Lemon peel is 
stomachic and carminative. Oil of lemon is stimulant and rubifacient when applied externally. 
Lemon juice is one of the best remedies for scurvy and serves as a refrigerant in febrile and 
inflammatory affections, acute rheumatism, dysentery and diarrhoea . The fruit is digestive 
carminative, stomachic, laxative, anthelmintic, stimulant, antiseptic and is useful in flatulence, 
dyspepsia, constipation, colic and helminathiasis 
16
.  
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Nutritional value per 100 g of Lemon Juice 
17
 
 Energy   - 129 kcal  
 Carbohydrates - 10.9 g  
 Protien  -  1.5 g  
 Fiber  -  1.3 g  
 Calcium   - 90 g  
 Phosphors  - 20mg  
 Iron   - 0.3mg  
 Thymine   -  0.02mg  
 Riboflavin  - 0.03,mg  
 Vitamin C  - 64 mg  
 Energy   - 59 Kcal  
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RECENT RESEARCHES ABOUT LEMON JUICE: 
1. Diuretic and Anti -Hypertension Activity 
Lemon juice is of value in Hypertension and Urinary diseases if used in the form of 
reconstituted Lemon drink (from Powder packet. Traditionally lemon juice has a vast number of 
uses including its anti-oxidant properties, anxiolytic, antidepressant effect as well as diuretic 
potential 
18
. 
2. Health and Medicinal properties of lemon 
Vitamin C present in the Lemon Juice. So it cures Scurvy. Lime juice and its oil are very 
beneficial for skin when consumed orally or applied externally. Lime juice has an irresistible 
scent which waters the mouth and thus aids primary digestion. Primarily, the ample of acids 
present in lime helps clear the excretory system by washing and cleaning off the tracts, just like 
some acids are used to clean floor and toilets. An overdose of lime juice with salt also acts as an 
excellent purgative without any side effects, thereby giving relief in constipation
19
. 
3. Antibacterial Activity of Fruits against Escherichia coli 
The Lemon Juice contains Antibacterial Activity against E.coli. ƒ More organisms can 
undoubtedly be analyzed for this antibacterial activity. Numerous fruits are unquestionably 
utilized to prevent foodborne illness diseases
 20
.  
4. Lemon Polyphenols Suppress Diet-induced Obesity 
Feeding with lemon polyphenols suppressed body weight gain and body fat 
accumulation by increasing peroxisomal β-oxidation through up-regulation of the mRNA level 
of ACO (acetyl CoA oxidase) in the liver and white adipose tissue, which was likely mediated 
via up-regulation of the mRNA levels of the peroxisome proliferator activated receptor-α 
(PPARα) 21. 
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              3. EUPHORBIA NERIIFOLIA, Linn,  E. lingularia. (Euphorbiaceae) 
 
Other Names:   
Tamil - Ilaikalli, Kalli,                                           
English – Common milk hedge 
Hindi – Pattonkisend, sij,  
Malayalam – Ilaikalli, kalli 
Telugu – Akujemudu 
Urdu – Zakum 
Marathi – Mingut 
Bengali - Mansasij  
 
Habitat: This leafless shrub is found in central india and cultivated in Bengal. 
Parts used: juice and root. 
Constituent’s: Euphorbon, resin, gum, caoutchouc, malate of calcium etc. 
Action: Juice is purgative and expectorant, locally rubefacient like that of E. antiquorum. Root is 
antispasmodic. 
Uses 
          Milk juice exuded from injured fleshy cylilndrical stems is used by Vaidyas in medicine as 
drastic cathartic and to relieve earache. Cloves, long-peppers, chebulic myrobalans and trivrit 
root etc., are soaked in this juice for some months and then dried, and used as a drastic purgative 
in the enlargement of liver and spleen, syphilis, dropsy, general anasarca, leprosy etc
28
. 
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For instance 
Take cloves 4 ounces and soak them into on seer of the milk for 40 or 50 days, then rub 
the whole into a mortar, the weight of this highly perfumed mass will be 12 ounces, now mix 
well in this mass, 360 grains of Rasakarpur called ”corrosive sublimate” of this whole 180 pills 
are prepared. 
 Two of such pills are administered to a patient at bed time, coated with a little fresh 
cream, so that the pills may be swallowed carefully without touching teeth. From the early 
morning till 10 a.m cathartic action will continue with watery stools. The patient should be given 
lukewarm aqua-ani seed 2 to 4 ounces after every motion.    
Bread with butter freely should be given as a diet. In 20 to 40 days suffering with any of 
above disease is cured, as has been seen in a number of such bad cases (Gupta).  As expectorant, 
especially in asthma, it is given in doses of 5 drops, mixed with a little honey of syrup. 
Dr. M.C. Koman tried it and found it very beneficial in asthma, He prepared a succus 
consisting of equal parts of the juice of this plant and simple syrup and administered it in doses 
of 10 to 20 minims three times a day in cases of asthma and found it to relieve fits completely
28
. 
The plant is bitter, pungent, laxative, carminative, alexipharmic, improves the appetite, 
useful in abdominal troubled, bronchitis, tumors, loss of consciousness, delirium, leucoderma, 
piles, inflammations, enlargements of the spleen, anemia, ulcers, fevers. 
The milk is pungent, laxative, good for abdominal troubles, tumors.  
 
Leucoderma 
 The leaves are heating carminative improve the appetite, good for tumors, pains, 
inflammations, abdominal swellings. (Ayurveda). 
The therapeutic properties are the same as those of E. tirucalli (Unani). 
The milky juice is used as a purgative and rubfacient. It enters into the composition of 
most of the drastic purgatives. 
The juice is employed in earache; mixed with soot it is applied to the eye in ophthalamia.  
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The juice of the leaves is a popular cure for earache in the Philippine islands. 
A success consisting of equal parts of the juice of this plant and simple syrups was 
prepared and administered in doses of 10 to 20 minims three times a day in cases of asthma, and 
was found to gibe relief to the fits of that disease. (Koman). 
The root is usefull in the antidotal and symptomatic treatment of snake bite (Mhaskar and 
Caius) and scorpion sting (Caius and Mhaskar), and equally usefull as an external application
29 
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RECENT RESEARCH ABOUT  E. NERIIFOLIA 
1. Pharmacological activities: 
Various plant parts or whole E. nerifolia extract and its isolates have been reported 
scientiﬁcally using various in-vivo and in-vitro experimental methods for anesthetic, analgesic, 
anti-anxiety, anti-convulsant, anti-psychotic, anti-arthritis, anti-carcinogenic, anti-diabetic,anti-
diarrhoeal, anti-inﬂammatory, anti-thrombotic, antimicrobial, antioxidant, antiulcer, cytotoxic, 
death-receptor expression enhancing, dermal irritation, diuretic, hemolytic ,immunomodulatory, 
radio protective, scorpion venom and wound healing properties
30
. 
 
2. Anti-Bacterial activity: 
Antibacterial  effect  was  found  in  the ethanol  and  chloroform  extract  of E.neriifolia 
when was tested against the organisms and it was believed to be due to  the  presence  of  tannins  
and flavonoids  which  have  been  shown  to possess antibacterial properties
31
.
  
 
3. Antiviral activity: 
 
Among of 23 compounds were isolated from ethanolic extract of leaves, 3-β-friedelanol exhibited 
more potent anti-viral activity than the positive control, actinomycin D implying the importance of the 
friedelane skeleton as a potential scaffold for developing new anti-HCoV-229E drugs
32
. 
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4. MATERIALS AND METHODS  
4.1 PALGARAI CHUNNAM: 
           4.1.1. Ingredients of Palagarai chunnam: 
   1. Palagarai 
    2. Lemon 
    3. Ilaikalli 
           4.1.2. Procurement and Authentication of Raw drugs: 
           Palagarai were procured from authenticate source of Raw Drug shop at Chennai. 
Identification and authentication done at Zoological survey of India, Chennai. The Herbs, 
Citrus limon(Lemon) and Ilaikkalli (Euphorbia nerifolia Linn.) were identified and 
authenticated by  Assistant Professor, Department of Medicinal Botany, National Institute of 
Siddha, Chennai-47. 
4.2 PREPARATION OF PALAGARAI CHUNNAM:  
4.2.1 Purification of palagarai: 
.                                  1.Palagarai ( Cypraea moneta )                                            - 100gm 
                                2.Elumichai Pazha Saaru (Citrus limon)                              - 300ml 
Take the above mentioned quantity of  Palagarai kept immersed in juice of lemon up 
to 24 hours
4
 . Then wash those Palagarai with pure water and then dried in sun light. 
4.2.2 Method of preparation: 
                  Take the above mentioned quantity of  Palagarai ( Cypraea moneta ) kept 
immersed in juice  of lemon upto 24 hours. Then wash those Palagarai  by using water.  
Those purified Palagarai have to be kept inside the 200g of Grinded  Ilaikalli ( Euphorbia 
nerrifolia Linn..)  Leaves  and it is covered by 5 layers of mud sealed cloth and dried well. 
Then it will be subjected into putam by using 30 cow dung cakes
33
.  After incineration 
remove the mud sealed cloth and collect the chunnam. Then it will be grind and have to be 
kept in air tight container. 
Route of administration: Oral  
Dose: 130 mg   
Adjuvant: Cow’s Milk 
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                                                            1. Purification of Palagarai 
                                       
 
 
 
 
                                    2.Palagarai before and after purification 
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                                                3. Ilaikkalli karkam 
 
 
 
 
 
 
 
                                                                               
                                                                                                                          
 
                                                           
                                               
  
                                      4. Palagarai kept inside the Ilaikkalli karkam 
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      5. Palagarai contained Ilaikkalli sealed by Mud plaster  
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                  6. Final product –Palagarai chunnam                                       
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                     ANALYTICAL STUDIES OF PALAGARAI CHUNNAM 
The test drug (Palagarai chunnam) was subjected to following analytical studies like 
physicochemical analysis, Biochemical Analysis and Quantitative analysis by using 
sophisticated instruments.  
4.3 QUALITATIVE ANALYSIS  
The test drug (Palagarai chunnam was studied by physicochemical parameters. This 
study was done at The Tamil Nadu Dr. M.G.R. Medical University No.69, Anna Salai, 
Guindy, and Chennai-600032.    
4.3.1 PHYSIOCHEMICAL ANALYSIS OF –PALAGARAI CHUNNAM 
1. Loss On Drying: 
     An accurately weighed 2g of Palagarai Chunnam formulation was taken in a tarred 
glass bottle. The crude drug was heated at 105
0
C for 6 hours in an oven till a constant 
weight. Percentage moisture content of the sample was calculated with reference to the 
shade dried material. 
2. Determination of total ash: 
              Weighed accurately 2g of Palagarai Chunnam formulation was added in crucible at a 
temperature 600
0
C in a muffle furnace till carbon free ash was obtained. It was calculated 
with reference to the air dried drug.  
3. Determination of acid insoluble ash: 
Ash above obtained, was boiled for 5min with 25ml of 1M Hydrochloric acid and 
filtered using an ash less filter paper. Insoluble matter retained on filter paper was washed 
with hot water and filter paper was burnt to a constant weight in a muffler furnace. The 
percentage of acid insoluble as was calculated with reference to the air dried drug. 
4. Determination of water soluble ash: 
Total ash 1g was boiled for 5min with 25ml water and insoluble matter collected on 
an ash less filter paper was washed with hot water and ignited for 15 min at a temperature 
not exceeding 450
0
C in a muffle furnace. The amount of soluble ash is determined by 
drying the filtrate. 
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5. Determination of water soluble Extractive: 
5gm of air dried drug, coarsely powered Palagarai Chunnam was macerated with 
100ml of distilled water in a closed flask for twenty-four hours shaking frequently. Solution 
was filtered and 25 ml of filtrated was evaporated in a tarred flat bottom shallow dish, 
further dried at 100
0
 C and weighted. The percentage of water soluble extractive was 
calculated with reference to the air dried drugs.   
 
6. Determination of alcohol soluble extractive: 
 
2.5gm. of air dried drugs, coarsely powdered Palagarai Chunnam was macerated 
with 50 ml. alcohol in closed flask for 24 hrs. With frequent shaking it was filtered rapidly 
taking precaution against loss of alcohol. 10ml of filtrate was then evaporated in a tarred 
flat bottom shallow dish, dried at 100
0
C and weighted. The percentage of alcohol soluble 
extractive was calculated with reference to air dried drug. 
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4.3.2. BIOCHEMICAL ANALYSIS 
  The bio-chemical analysis of Palagarai chunnam as done at Biochemistry lab  
National Institute of Siddha, Chennai-47. 
 
 
 
 
 
 
 
 
S.NO EXPERIMENT 
 
OBSERVATION INFERENCE 
1. Appearance of the sample   White  in color  
2. Solubility: 
 
     A little of the sample is shaken 
well with distilled water 
 
Sparingly soluble Presence of silicate 
3. Action of heat: 
 
     Asmall  amount of the sample 
is taken in a dry test tube and 
heated gartly at first and then 
strong. 
 
White fumes evolved Presence of 
carbonate 
4. Flame test: 
 
    A small amount of the sample is 
made into a paste with con.HCL in 
a watch glass and introduced into 
non luminous part of the Bunsen 
flame. 
 
Bluish green flame 
not appeared. 
Absence of copper 
5. Ash test: 
 
    A filter paper is soaked into a 
mixture of sample and cobalt 
nitrate solution and introduced 
into the Bunsen flame and ignited 
 
No yellow colour 
flame 
Absence of sodium 
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Preparation of extract: 
5 gm of palagarai chunnam is weighed accurately and placed in a 250ml clean beaker 
and added with 50 ml of distilled water. Then it is boiled well for about 10 minutes. Then it is 
cooled and filtered in a 100ml volumetric flask and made up to 100ml with distilled water. 
S.NO EXPERIMENT OBSERVATION INFERENCE 
 
TEST FOR ACID RADICALS 
 
1. Test for sulphate: 
 
     2ml of the above prepared 
extract is taken in a test tube to this 
added 2ml of 4% ammonium 
oxalate solution.  
 
No cloudy appearance 
present. 
Absence of sulphate. 
2.  Test for chloride: 
 
     2ml of the above prepared 
extract is added with diluted HNo3 
till the effervescence ceases. Then 2 
ml of silver nitrate solution is 
added. 
 
No cloudy appearance 
present. 
Absence of chloride.  
3. Test for phosphate: 
 
     2ml of the extract is treated with 
2ml of ammonium molybdate 
solution and 2ml of con. Hno3. 
 
No cloudy yellow 
appearance present. 
Absence of 
phosphate. 
4. Test  for carbonate: 
 
     2ml of the extract is treated with 
2ml magnesium sulphate solution. 
 
Cloudy appearance 
present. 
Presence of 
carbonate. 
5. Test for sulphide: 
 
     1gm of the substance is treated 
with 2ml of con HCL. 
 
 
No rotten egg 
smelling gas evolved. 
Absence of sulphide. 
6. Test for fluoride and oxalate: 
 
     2ml of extract is added with 2ml 
of dil.Acetic acid and 2ml calcium 
chloride solution and heated. 
 
 
 
 
No cloudy 
appearance. 
Absence of fluoride 
and oxalate. 
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7.  
 
Test for nitrite: 
 
    3 drops of the extract is placed on 
a filter paper, on that 2drops of 
acetic acid and 2 drops of benzidine 
solution is placed.  
 
 
No characteristic 
changes. 
 
Absence of nitrite. 
8. Test for borate: 
 
     2 pinches of the substance is 
made into paste by using sulphuric 
acid and alcohol (95%) and 
introduced into the blue flame. 
 
Bluish green colour 
flame not appeared. 
Absence of borate. 
 
II. Test for basic radicals 
 
1. Test for lead: 
 
     2ml of the extract is added with 
2ml of potassium iodide solution. 
 
No yellow precipitate 
is obtained. 
Absence of lead. 
2.  Test for copper: 
 
     One pinch of substance is made 
into paste with con Hcl in a watch 
glass and introduced into the non 
luminuous part  of flame. 
 
Blue colour flame not 
appeared. 
Absence of copper. 
3. Test for aluminium: 
 
      2ml of the extract sodium 
hydroxide is added in drops to 
excess 
 
Yellow colour 
appeared 
Presence of 
aluminium 
4. Test for iron: 
 
     2ml of extract add 2ml of 
ammonium thiocyanate solution and 
2ml of con HNO3 is added 
 
 
Mild red colour 
appeared 
Presence of iron 
 
5. Test for zinc: 
 
     2ml of the extract sodium 
hydroxide solution is added in drops 
to excess. 
 
 
 
 
White precipitate is 
formed. 
Presence of zinc 
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6. Test for calcium: 
 
     2ml of the extract is added with 
2ml of 4% ammonium oxalate 
solution. 
Cloudy appearance 
and white precipitate 
obtained 
Presence of calcium 
7. Test for magnesium: 
 
     2ml of extract sodium hydroxide 
solution is added in drops to excess. 
 
White precipitate is 
obtained 
Presence of 
magnesium 
 
8. Test for ammonium: 
 
     2ml of extract few ml of 
nessler’s reagent and excess of 
sodium hydroxide solution are 
added. 
 
No  brown colour 
appeared 
Absence of 
ammonium 
9. Test for potassium: 
 
      A pinch of substance is treated 
with 2ml of sodium nitrite solution 
and then treated with 2ml of cobalt 
nitrate in 30% glacial acetic acid. 
 
Yellowish precipitate 
is obtained 
 
Presence of 
potassium 
10. Test for sodium: 
     2 pinches of the substance is 
made into paste by using HCL and 
introduced into the blue flame of 
Bunsen burner. 
 
 
No yellow colour 
flame appeared 
Absence of sodium 
 
11 Test for mercury:  
 
     2ml of the extract is treated with 
2ml of sodium hydroxide solution 
 
 
 
 
No yellow precipitate 
is obtained 
 
Absence of mercury 
12. Test for arsenic: 
     2ml of the extract is treated with 
2ml of sodium hydroxide solution. 
 
 
 
 
 
 
 
 
 
 
No brownish red 
precipitate is obtained 
Absence of arsenic 
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III. Miscellaneous 
 
1.  Test for starch: 
 
     2ml of extract is treated with 
weak iodine solultion. 
 
Sky blue colour 
developed 
Presence of starch 
 
2. Test for reducing sugar: 
 
     5ml of benedict’s qualitative 
solution is taken in a test tube and 
allowed to boil for 2 minutes and 
added 8 to 10 drops of the extract 
and again boil it for 2 minutes. The 
colour changes are noted. 
 
No brick red colour 
developed 
Absence of reducing 
sugar 
3. Test for the alkaloids: 
 
     a. 2ml of the extract is treated 
with 2ml of potassium iodide 
solution. 
 
     b. 2ml of extract is treated with 
2ml of picric acid. 
 
     c. 2ml of the extract is treated 
with 2ml of phosphor tungstic acid. 
 
Yellow colour 
developed 
Presence of alkaloids 
4.  Test for tannic acid: 
 
     2ml of extract is treated with 2ml 
of ferric chloride solution. 
 
No black precipitate is 
obtained 
Absence of tannic 
acid  
5. Test for unsaturated compound: 
 
    2ml of extract 2ml of potassium 
permanganate solution is added. 
 
Potassium 
permanganate is not 
decolourised. 
Absence of 
unsaturated 
compound.  
 
6. Test for amino acid: 
 
     2 drops of the extract is placed 
on a filter paper and dried well. 
 
Not violet colour 
developed. 
Absence of amino 
acids. 
7. Test for type of compound: 
 
     2ml of the extract is treated with 
2ml of ferric chloride solution. 
 
Red colour developed. Anti pyrine, aliphatic 
amino acids and 
meconic acid are 
present. 
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4.4   QUANTITATIVE ANALYSIS  
4.4.1 TRACE ELEMENTS ANALYSIS OF PALAGARAI CHUNNAM: 
           The analysis of heavy metals and trace elements were estimated by using Inductively 
coupled plasma optical emission spectrometry (ICP- OES). The Experimental Procedure was 
done at SAIF, IIT Madras, Chennai-36. 
ICP-OES:      
Perkin Elmer Optima 5300DV was used for standard ICP-OES analysis. The 
optimized operating conditions are given in table 1, the wavelength of analytical lines are 
given below and the test drug Palagarai chunnam underwent microwave digestion for sample 
preparation.   
 ICP- OES Operating Conditions:  
 Rf frequency: 40 M Hz   
 Range: 165 – 782 nm  
 Detection limit:  Up to ppm level using SCD detector 
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4.4.2 FOURIER TRANSFORM INFRARED SPECTROSCOPY (FTIR)  
Fourier transform infrared spectroscopy (FTIR) is a technique which is used to obtain 
an infrared spectrum of absorption or emission of a solid, liquid or gas. An FTIR 
spectrometer simultaneously collects high spectral resolution data over a wide spectral range. 
This confers a significant advantage over a dispersive spectrometer which measures intensity 
over a narrow range of wavelengths at a time.  
          The term Fourier transform infrared spectroscopy originates from the fact that a Fourier 
transform (a mathematical process) is required to convert the raw data into the actual 
spectrum. For other uses of this kind of technique, see Fourier transform spectroscopy. 
The interference pattern obtained from a two beam interferometer as the path 
difference between the two beams is altered, when Fourier transformed, gives rise to the 
spectrum. The transformation of the interferogram into spectrum is carried out 
mathematically with a dedicated on-line computer. 
The Perkin Elmer Spectrum1 FT-IR instrument consists of globar and mercury vapor 
lamp as sources, an interferometer chamber comprising of KBr and mylar beam splitters 
followed by a sample chamber and detector. Entire region of 450-4000 cm-1 is covered by 
this instrument. The spectrometer works under purged conditions. Solid samples are 
dispersed in KBr or polyethylene pellets depending on the region of interest. This instrument 
has a typical resolution of 1.0 cm-1. Signal averaging, signal enhancement, base line 
correction and other spectral manipulations are possible. 
Instrument details 
Model              :   Spectrum one : FT-IR Spectrometer 
Scan Range      :   MIR 450-4000 cm-1 
Resolution       :   1.0 cm-1 
Sample required:  50 mg, solid or liquid. 
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ANALYSIS OF PARTICAL SIZE   
  The particle size of the Palagarai chunnam was determined using High resolution 
scanning electron microscopy (HR SEM). The Experimental Procedure was done at SAIF, 
IIT Madras, Chennai-36.  
4.4.3 HR SEM : 
   A scanning electron microscope (SEM) is a type of electron microscope that 
produces images of a sample by scanning the surface with a focused beam of electrons. The 
SEM analysis is carried out by using FEI-Quanta FEG 200-High Resolution Instrument 
Resolution       :   1.2 nm gold particle separation on a carbon substrate  
       Magnification   :   From a min of 12 X to greater than 1,00,000 X.  
Calculation of the particle size:  
The horizontal line in the right corner of the micrograph corresponds to micron in 
length would be given. A comparison could be made between the length of the particles 
visible in the micrograph with this line and the length of the particle was calculated. 
Application:   
To evaluate grain size, particle size distributions, material homogeneity and 
intermetallic distributions.   
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       4.5   TOXICITY STUDIES OF PALAGARAI CHUNNAM 
 Preclinical safety evaluation Palagarai chunnam with acute and subacute 
toxicity study carried out as followed 
Principles of laboratory animal care were followed and the Institutional Animal 
 
Ethical Committee approved the use of animals and the study design. Institutional 
 
Animal Ethics Committee approval number: NIS/IAEC/II/08/2016 dated 29.9.2016 
 
For acute toxicity study and repeated dose 28-day oral toxicity study. 
 
4.5.1  ACUTE TOXICITY STUDY OF PALAGARAI CHUNNAM
 
Experimental Animals:   
Species  : Wistar Albino Rats 
Sex : Female 
Age/weight : 6 weeks/140-160gm b.wt 
Acclimatization Period : 7 days prior to dosing 
Housing : Polypropylene cages bedding with husk 
Husbandry : 12-h light/12-h dark cycle/ 
  Room temperature 22°C ± 3°C and 
  
Relative humidity 30–70% 
 
Feed and Water : Rodent pelleted feed 
  
RO purified water  
 
Identification : Animals will be kept in 
  Polypropylene cages and marked 
   
Experimentation Details of Acute Toxicity Study: 
Groups/Treatment regimen : Grouped by randomization 
Test Guideline : OECD-423 
Duration of the exposure to test 
drug : Once single dose 
No of Animals : 3 Female/ group 
Control group : Adjuvant (Milk) 
Test groups : Palagarai chunnam 300,2000 mg/kg b.wt 
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The Female Albino Rats of weighing 150-200g were obtained from authorized 
 
animal breeders of the animal laboratory in TANUVAS, Madhavaram, and Chennai 
 
and stocked in the animal house at National Institute of Siddha, Chennai.  
 
            Animals were housed in a cage at 22°C ±3°C and relative humidity 30–70% and 
have free access to standard rat pellet diet. The animals are divided into three groups 
(Group I, II &III). Each group contains 3 female Wistar albino rats. Group I served as a 
control and treated with milk.  
            The remaining two groups were treated with 300mg/kg.b.wt and 2000mg/kg.b.wt 
dosage of Palagarai chunnam by oral route after 12 hrs fasting with free from water. After 
drug administration behavioral parameters are monitored for the first 4 hours 
continuously (1/2 hr, 1hr, 2 hr, 3 hr,4 hr) and noted. The animals that the die within this 
period will be subjected to necropsy. Remaining animals will be weighed and sacrificed 
under the injection of Pentothal Sodium on the 15
th
 day of the Study period. The 
toxicological effect was assessed on the basis of mortality. 
 
Route of administration 
 
Oral route was selected because it is the normal route of clinical administration. 
 
Administration of Dose 
The animals were fasted (only food was withheld) for 12hrs and weighed prior to 
dosing. Three animals were used for each step. A single dose of the solution 
(300,2000mg/kg/b.wt) was consecutively administered by oral gavage using 
intubation cannula. The food was withheld for another 4hrs after dosing of the drug. 
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Observations were made and recorded systematically and continuously observed 
after the substance administration as per the guidelines. 
 
 ½ hour, 1 hour, 2 hours, 4 hours and up to 24 hours observation 
 
 All rats were observed twice daily for 14 days

 Body weight  were Calculated weekly once

 Feed & water intake were Calculated daily


Cage side observation 
The animals were monitored for behavioral parameters like Alertness, 
Aggressiveness, piloerection, Grooming, Gripping, Touch Response, Motor Activity, 
Tremors, Convulsions, Muscle Spasm, Catatonia, Muscle relaxant, Hypnosis 
Analgesia, Lacrimation, Exophthalmos, Diarrhea, Writhing, Respiration, Mortality. 
Gross necropsy: 
At the end of the 14 
th
 day, all the animals were sacrificed by using the injection 
of Pentothal sodium Gross necropsy includes examinations of the external surface of 
the body, all orifices, cranial, thoracic and abdominal cavities and their contents. 
Brain, eye, lungs, heart, spleen, liver, kidneys, adrenals, uterus, of all animals. 
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      4.5.2   28-DAY ORAL TOXICITY STUDY OF  PALAGARAI  CHUNNAM 
 
Experimental Animals:   
Species : Wistar Albino Rats 
Sex : Male and Female 
Age/weight   at start of test : 6 weeks/140-160g b.wt 
Acclimatization Period : 7 days prior to dosing 
Housing : Polypropylene cages bedding with husk 
   
Husbandry : 12-h light/12-h dark cycle/ 
  Room temperature 22°C ± 3°C  and 
  Relative humidity 30–70% 
Feed and Water : Rodent pelleted feed 
  
RO purified water ad libitum 
 
Identification : Animals will be kept in Polypropylene 
cages and numbered 
    
   
 
Experimentation Details of Repeated dose 28 days Toxicity Study: 
 
Groups/Treatment regimen : Grouped by randomization 
Test Guideline : OECD-407 
Length of exposure to test substance : 28 days 
No of Animals : 5 Female+5 Male / group 
  
Control group                                                                                                        : Adjuvant (Milk) 
Test group     :        Low dose, mid dose, High dose 
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          The animals weighted in range of 150-200 gm of 20 male and 20 female Wistar 
albino rats are used for 28 days repeated oral toxicity study. The animals are divided into 
four groups. Each group contains 10 animals (5 female and 5 Male). The first group 
treated as control and second, third, fourth groups were treated with Group 1.Control  - 
Milk,  Group 2.Low dose -11.7mg/kg/b.wt, Group 3.Mid dose -58mg/kg/b.wt, 4.Group 
.High dose.- 117mg/ kg/b.wt . 
           Above mentioned dose of palagarai Chunnam mixed with milk for 28 days 
respectively after 12 hrs. of fasting with   free from water. The low dose, mid dose and 
high dose of test drug will be calculated from human therapeutic dose based on surface 
area by using the conversion table of Paget and Barnes (1964). The control animals were 
administered with milk as adjuvant. 
           The administration was given by oral, once daily for 28 consecutive days. The 
animals were observed the behavioral parameters for the study period. Body weight of the 
animal was being monitored at weekly intervals. Food & water intake were Calculated 
daily. All the animals were sacrificed at the end of the study (29 days) by using the intra 
peritoneal injection of Pentothal Sodium as prescribed dose level. Blood was collected 
from the anesthetized animals from the Abdominal aorta for the following investigations 
like Hematology and Biochemical analysis. Gross pathological changes were monitored 
in all the organs then the vital organs were  preserved and subjected to  Histopathological 
examination. 
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Observation: 
Experimental animals were kept under observation throughout the course of study 
for the following 
 All rats were observed twice daily for 28 days

 Body weight were Calculated weekly once

 Feed & water intake were Calculated daily
 
a.Cage side observation 
The animals were monitored for behavioral parameters like, Alertness, 
Aggressiveness, piloerection, Grooming, Gripping, Touch Response, Motor Activity, 
Tremors, Convulsions, Muscle Spasm, Catatonia, Muscle relaxant, Hypnosis Analgesia, 
Lacrimation, Exophthalmos, Diarrhea, Writhing, Respiration, Mortality. 
Laboratory Investigations: 
On the 29
th
 day, the animals were fasted overnight, then anesthetized to collect 
blood samples from the abdominal aorta in two tubes: one with EDTA for hematological 
parameters, another one without any anticoagulant and was centrifuged at 4000 rpm at 
4°C for 10 minutes to obtain the serum for biochemical parameters. 
Hematological Investigations: 
Blood samples of control and experimental rats were analyzed for haemoglobin 
(Hb), total red blood corpuscles (RBC), white blood corpuscles (WBC) count, Platelet, 
Mean corpuscular volume (MCV), Mean corpuscular hemoglobin (MCH), were 
calculated by auto analyzer. 
Biochemical Investigations: 
Serum samples of control and experimental animals were analyzed for, Bilirubin, 
BUN, Creatinine, Triglyceride, Total Cholesterol, HDL, LDL, VLDL, using standard 
methods. Activities of glutamate oxaloacetate transaminase/Aspartate aminotransferase 
(GOT/AST), glutamate pyruvate transaminase/ Alanine aminotransferase (GPT/ALT) 
were estimated as per the colorimetric procedure. 
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Necropsy: 
             All the animals were sacrificed on the 29
th
 day and satellite group were 
sacrificed on after 14 days. Gross necropsy includes examinations of the external surface 
of the body, all orifices, cranial, thoracic and abdominal cavities and their contents. 
Brain, eye, lungs, heart, spleen, liver, kidneys, adrenals, sex organs, of all animals were 
recorded. 
Histopathology: 
The organs included liver, kidneys, spleen, brain, heart, lungs and stomach of 
the animals were preserved, and they were subjected to Histopathological examination. 
Histopathological investigation of the vital organs was done. The organ pieces 
(3-5µm thick) of all the animals (low, mid, high) a n d satellite group w e r e preserved 
and fixed in 10% formalin for 24 hrs. Samples were dehydrated in an auto technic and 
then cleared in benzene to remove absolute alcohol. Embedding was done by passing the 
cleared samples through three cups containing molten paraffin at 50
o
C and then in a 
cubical block of paraffin made by the “L” molds. It was followed by microtome and the 
slides were Prepared then stained with Haematoxylin-eosin. 
Statistical analysis: 
Findings such as body weight changes, food consumption, water intake, and 
hematology and biochemical analysis were subjected to One-way ANOVA Dunnet’s test 
using a computer software program followed by D Graph Pad Instat-3 
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                           5. RESULTS 
 Standardization of Chunnam in Siddha Aspect 
                      A small amount of turmeric powder was taken. Then same amount of 
Palagarai chunnam is mixed with turmeric powder, while adding water, the colour of the 
mixture was turned into red colour
34
. 
 
1.Turmeric Powder                                        2-Palagarai chunnam and turmeric powder                       
                          
 
                                                3. Chunnam confirmation 
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     5.1 QUALITATIVE ANALYSI S 
Table 1: Organoleptic analysis of –Palagarai chunnam 
S.no Parameters Results Method of Testing 
    
1. Colour Dull white By visual 
    
2. Odour Odourless Olfactory examination 
     
3 Nature Fine powder By visual 
     
 
 From Table 1, The Organoleptic characters shows that Palagarai chunnam is dull white 
in color and odorless powder 
Table 2: Physiochemical analysis of –Palagarai chunnam 
S.no Parameters Percentage 
1 Loss on drying Less than 1% 
2 Solubility Soluble in water& alcohol. 
3 pH At 25 
0
C (1% w/w solution)                  7.87% 
4 Total ash value 97.01% 
5 Acid insoluble ash 34.69% 
6 Water soluble ash 16.96% 
7 Water soluble extraction Less than 1% 
8 Alcohol soluble extraction Less than 1% 
 
From Table 2, The Physico-chemical analysis of Palagarai chunnam   explained in the 
parameters such as Moisture content, Total ash value, Acid insoluble ash, Water soluble 
ash, Water soluble extraction, Alcohol soluble extraction and pH are within the normal 
limits. The drug with pH of 7.87%. It is easily soluble in water, alcohol and acetone and 
ether. 
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Table 3: Biochemical analysis of   Palagarai chunnam 
 Test for Basic radicals 
 
S.no Procedures  Palagarai chunnam 
   
1. Test for Lead  
  - 
2. Test for Copper - 
   
3. Test for Aluminum + 
   
4. Test for Ferrous iron + 
   
5. Test for Zinc + 
   
6. Test for Calcium + 
   
7. Test for Magnesium  
  + 
8. Test for Ammonium  
  - 
9. Test for Potassium  
  + 
10. Test for Arsenic - 
   
  11. 
 Test for Mercury                           - 
  12 
 Test for Sodium                           - 
 
 
           The table no:3 explained that presence of Aluminum, Ferrous iron, Zinc, Calcium, 
Magnesium in the test drug. 
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Table-4: Test for Acidic radicals 
 
S.no Procedures Palagarai chunnam 
   
1.   Test for Sulphate  
  + 
2.  Test for Chloride + 
   
3.           Test for Phosphate _ 
   
       4            Test for Carbonate  
  +. 
5.    Test for Sulphide _ 
   
6. Test for Fluoride and oxalate                  _ 
   
7         Test for Nitrate                  _ 
     8         Test for borate                  _ 
 
 
Table-5: Test for Miscellaneous 
 
S.no Procedures  Palagarai chunnam 
   
1. Test for Starch                 + 
   
2. Test for Reducing sugar                 _ 
   
3. Test for Alkaloids                 + 
   
4. Test for Amino Acids                 _ 
   
5. Test for Tannic acids                 _ 
   
6 Test for type of compound 
Anti pyrine, aliphatic 
amino acids and 
meconic acid are 
present. 
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5.2 QUANTITATIVE ANALYSIS 
 
A .ICP-OES: 
 
                             Sample Weight of test drug: 0.35300gm 
 
 Table no:6 Result of Quantitative analysis by ICP-OES for Palagarai chunnam 
   
S.No: ELEMENTS WAVE LENGTH   RESULTS  (in mg/L) 
  IN NM  
    
1. Aluminium Al 396.152 30.213 
    
2. Arsenic As 188.979 BDL 
    
3. Calcium Ca 315.807 625.150 
    
4. Cadmium Cd 228.802 BDL 
    
5. Copper Cu 327.393 BDL 
    
6. Iron Fe 238.204 45.016 
    
7. Mercury Hg 253.652 BDL 
    
8. Potassium K 766.491 3.004 
    
9. Magnesium Mg 285.213 1.004 
    
10. Sodium Na 589.592 BDL 
    
11. Nickel Ni 231.604 BDL 
    
12. Lead Pb 220.353 BDL 
    
13. Phosphorus P 213.617 38.541 
    
14. Sulphur S 180.731 45.224 
    
15. Zinc Z 206.200 10.018 
    
 
 
*BDL – Below Detection Limit 
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B. FT-IR Analysis of Palagarai chunnam 
                                                                 
Graph-1: Graph  of  Characteristic  IR  absorption  frequencies  of  Organic 
 
Functional Groups for unpurified raw drug Palagarai. 
 
 
 
 
 
 Fourier Transform Infra Red Spectroscopy (FTIR) analysis of Palagarai chunnam 
shows the presence of vibrational band observation around ~ 1420 to 1500 cm
-1
 and 860 to 
875 cm
-1
 confirms is attributed to the presence of calcium carbonate. The FTIR results 
shows the observed N-H stretch, O-H stretch, H-C-H stretch, C=O stretch, N-H stretch, C-
C=C symmetric stretch, H-C-H bend, C-O stretch, C -H bend, C-C stretch which indicates 
that the presence of functional groups Amide, Phenols and alcohols, Alkanes, Aldehyde, 
Amine, Alkenes, Alkanes , Ester , ether, Alkyne. 
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C. SCANNED ELECTRON MICROSCOPY  
 
Determination of Particle size of Palagarai chunnam 
 
Figure-1:  SEM Image of Palagarai chunnam  
 
     
  
 
 
The morphology of the Palagarai chunnam drug can be determined by SEM (FEI 
Quanta). A representative portion of each sample must be  sprinkled onto a double side 
carbon tape and mounted on aluminium stubs, in order to get a higher quality secondary 
electron image for SEM examination. We have observed from SEM photographs that 
particles are spherical in shapes and sizes are in the range from 1 micron to 3 microns. 
Although the particle sizes of different batches showed similarity, it seems that these 
particles are aggregates of much smaller particles. When dispersed in an aqueous medium, 
these preparations form a negatively charged hydrophobic particle suspension. This 
hydrophobicity gives these particles a tendency to aggregate together to form larger 
particles. Palagarai Chunnam exhibited larger sizes and agglomeration of the particles. 
Therefore, the comparatively larger size may be due to the agglomeration of the particles by 
repeated cycles of calcinations involved in preparation 
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1. ACUTE TOXICITY STUDY 
 
Table.7 Behavioral Signs of Acute Toxicity Study 
 
 
No Dose 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
 Mg/kg                     
1. Control + - - + + + - - - - - - - - - - - - + - 
                      
2. 300 + - - + + + - - - - - - - - - - - - + - 
                      
3. 2000 + - - + + + - - - - - - - - - - - - + - 
                      
  
1. Alertness 2. Aggressiveness 3. Pile erection 4. Grooming  5. Gripping 6. Touch 
Response 7. Decreased Motor Activity 8. Tremors 9.Convulsions 10. Muscle Spasm 
11. Catatonia 12. Muscle relaxant 13. Hypnosis 14.Analgesia 15.Lacrimation 16. 
Exophthalmos 17.Diarrhoea 18.Writhing 19.Dyspnoea 20. Mortality 
                           Note: 
 + Presence of activity  
                       -   Absence of activity 
All the data were summarized in the form of (table) revealed that there was no 
abnormal signs and behavioral changes in all animals at the dose level of  300,2000 
mg/kg body weight administered orally, during the study period.    
There was no mortality observed after dosing of Palagarai chunnam upto 
2000mg/kg body weight This indicates that LD50 of Palagarai chunnam is more than 
2000mg/kg b.wt. 
There were no changes in skin and fur, eyes and mucous membranes of all 
animals. The eating, drinking habit, sleep pattern, locomotion were normal in all 
animals and no changes in body weight as compared to control group. At the end of the 
14
th 
day, necropsy was performed and there was no abnormality seen in test groups as 
compared to control group during the examination. 
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28 DAY REPEATED DOSE ORAL TOXICITY STUDY (FOOD CONSUMPTION) 
  
Food consumption of the animals significant difference in Food intake the 
test group animals were observed when compared with control group during the 
study period. (Table 8 ), There was significant difference occurs in test groups  
compared with control group.  but they are within physiological limit. 
     Table  8:  Food (g/day) intake of albino rats exposed to Palagarai chunnam 
 
Dose 
1
st
 day 7 
th  
 day 14 
th
 day 21
st
 day 28 
th
 day (mg/kg/ day) 
      
      
Control 10.25±0.16 11.25±0.18 12.5±0.28 12.8±0.25 13.15±0.18 
      
LD 12.8±0.21** 13.8±0.21** 13.95±0.38* 14.65±0.38** 16.3±0.32** 
      
MD 12.45±0.16** 13.5±0.45** 14.8±0.54** 16.8±0.54* 16.95±0.15** 
      
HD 12.15±0.158** 14.95±0.17** 15.15±1.25** 16.95±0.71* 18.65±0.25** 
      
 
Values were expressed as mean± S.D. for N=10  rats in each group one-way 
ANOVA followed by Dunnett’s test. Significant indicates *P<0.05, **P<0.01. 
 
Food (g/day) intake of albino rats Exposed to Palagarai chunnam- Figure 4    
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28 DAY REPEATED DOSE ORAL TOXICITY STUDY (WATER 
CONSUMPTION) 
 
    Water consumption the difference in Water intake of control and test group of 
animals observed during the study period. There was significant difference occurs in 
the test group compared with control group (Table 9). 
Table: 9  Water (ml/day) intake of albino rats exposed to Palagarai chunnam 
 
Dose 1 st day 7 th day 14 th day 21 st day 28 th day 
 (mg/kg/day)      
      
Control 16.45±0.35 21.65±0.45  23.56±0.38 22.38±0.25 24.95±0.95 
      
LD 16.95±0.25 19.84±0.35**  22.65±0.15* 22.15±0.18 26.35±0.25** 
      
MD 17.15±0.35 21.65±0.35 23.95±0.18 24.35±0.28* 28.95±0.28** 
      
HD 18.36±0.46 21.45±0.24 22.65±0.28* 23.55±0.38** 28.83±0.24** 
       
 
   Values were expressed as mean± S.D. for N=10  rats in each group one-way      
ANOVA  followed by Dunnett’s test. Significant indicates *P<0.05,**P<0.01 
 
Water (ml/day) intake of albino rats Exposed to Palagarai chunnam-Figure 5 
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         28 DAY REPEATED DOSE ORAL TOXICITY STUDY-BODY WEGHT 
Body weight of both control and test dose group revealed normal body weight 
throughout the study .There is significant change occur in body weight of mid and 
high dose group compared with control group (Table 10). 
 
Table:10 Body weight (g) changes of albino rats (male) exposed to Palagarai 
chunnam 
 
Dose 
1
st
 day 
    
Mg/kg 7 th day 14 th day 21 st day 28 th day 
      
Control 155±12.70 161±13.50 172±15.20 180.66±18.45 194±19.20 
      
LD 158.2±10.05 168.3±14.07 178.45±16.52 190.33±18.71 205.66±18.45 
      
MD 178±11.50** 188±12.51**  200.23±12.36* 210.23±15.6* 221.33±20.64 
      
HD 181.66±7.50* 189.33±8.02* 199±9.21 208±8.29* 238.33±10.50** 
       
Values were expressed as mean± S.D. for N=10  rats in each group one-way 
ANOVA followed by Dunnett’s test. Significant indicates *P<0.05,**P<0.01 
 
Body weight (gm.) changes of albino rats (male) exposed to Palagarai 
chunnam-Figure -6 
 
                                                                                                                                 RESULTS 
 
Preclinical safety evaluation of palagarai chunnam Page 59 
 
 
28 DAY REPEATED DOSE ORAL TOXICITY STUDY- BODY WEGHT 
 
Body weight of both control and test dose group exhibited normal body 
weight throughout the study period. (Table 11) 
 
Table:11 Body weight (g) changes of albino rats (female) exposed to 
Palagarai chunnam  
 
Dose      
(mg/kg/day) 1 st day 7 th day 14 th day 21 st day 28 th day 
      
Control 148±4.55 154.66±4.66 164±5.35 174.33±8.08 186.33±6.78 
      
LD 143.23±5.14 152.66±6.09 165.66±8.09 176±8.18 192.33±6.02 
      
MD 147.66±6.09 157.35±6.68 169.56±6.85 181.65±5.15 194.33±8.72 
      
HD 152.66±5.85 159.66±6.80 164.15±6.25 177±5.55 195.35±7.15 
       
Values were expressed as mean± S.D. for N=10 rats in each group one-way 
ANOVA followed by Dunnett’s test. Significant indicates *P<0.05,**P<0.01 
Body weight (g) changes of albino rats (female) exposed to Palagarai 
chunnam -Figure-7 
 
 
 
                                                                                                                                 RESULTS 
 
Preclinical safety evaluation of palagarai chunnam Page 60 
 
 
28 Day Repeated Dose Oral Toxicity Study 
 
    The results of the Hematological investigations conducted at the end of the study, 
the test groups revealed slightly significant changes in levels of hematological 
parameters, when compared with control group. (Table12) 
 
 
Table: 12 Effect of Palagarai chunnam on Hematological Parameters 
 CONTROL LD MD HD 
RBC (×10 6 μl) 5.68±0.35 6.02±0.52* 6.09±0.57 6.18±0.91 
WBC (×10 3 μl) 9.6±1.42 8.37±1.39 8.5±2.85 7.78±2.16 
PLT (×10 3 μl) 768.5±89.14 685.5±142.54 583.5±94.52** 765.7±96.55 
HGB (g/dl) 11.64±1.69 12.16±1.37 13.2±1.23 13.8±1.59** 
MCH (pg) 18.39±2.47 18.87±1.71 20.97±0.87** 22.41±1.46** 
MCV (fl) 56.98±2.73 59.81±3.81 58.86±4.36 59.7±5.76 
Neutrophils10
3
mm
3
 2±0.52 1.91±0.42 1.41±0.33** 1.52±0.23* 
Eosinophil’s (%) 1.58±0.22 1.41±0.24 1.44±0.19 1.54±0.29 
Basophils (%) 0.2±0.42 0.2±0.42 0.2±0.42 0.1±0.32 
Lymph (%) 68.14±5.41 83.42±7.17** 79.07±9.06** 71.97±7.94 
Mon (%) 3.82±0.94 2.59±0.94 4.13±0.79 3.76±1.02 
    Values were expressed as mean± S.D. for N=10 rats in each group one-way 
ANOVA followed by Dunnett’s test. Significant indicates *P<0.05,**P<0.01 
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FIGURE :8 
 
Effect of Palagarai chunnam on Hematological Parameters-RBC 
 
     
              
 
 
FIGURE :9 
 
Effect of Palagarai chunnam on Hematological Parameters-WBC 
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FIGURE :10 
Effect of Palagarai chunnam on Hematological Parameters-HEMOGLOBIN 
 
               
 
FIGURE :11 
Effect of Palagarai chunnam on Hematological Parameters-Differential count 
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28 Day Repeated Dose Oral Toxicity Study 
 
Biochemical investigations were conducted at the end of the study and the 
results were recorded. In test groups there was significant changes present in 
biochemical parameters (Lipid profile) , when compared with the control group. At 
the values were normal biological limits. (Table 13) 
 
Table:13 Effect of Palagarai chunnam on biochemical parameters-Lipid profile 
 
 CONTROL LD MD HD 
Total cholesterol 
(mg/dl) 
109.26±15.22 113.93±10.09 129.17±8.41** 127.4±11.56** 
HDL (mg/dl) 60±4.74 58.2±8.26 61.1±8.79 58.6±7.95 
LDL (mg/dl) 43.6±13.21 37.2±9 49.3±7.01 48.6±11.14 
VLDL (mg/dl) 12.25±1.34 17.2±4.57** 15.04±2.54 17.66±4.11** 
TGL (mg/dl) 50±4.69 41±10.39 37.9±7.99** 36.8±9.93** 
Values were expressed as mean± S.D. for N=10 rats in each group one-way 
ANOVA followed by Dunnett’s test. Significant indicates *P<0.05,**P<0.01 
 
        Effect of Palagarai chunnam on Biochemical parameters –Figure 12 
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28 Day Repeated Dose Oral Toxicity Study 
 
The results of the renal functions test conducted at the end of study, test 
groups revealed marginally significant changes in levels of renal parameters, when 
compared with control group.(Table 14) 
 
Table: 14 Effect of Palagarai chunnam on Renal Parameters 
 
 CONTROL LD MD HD 
BUN (mg/dl) 12.5±1.58 15.1±2.47* 15.5±2.17** 14.7±2.16 
Serum Creatinine 
(mg/dl) 
0.57±0.15 0.63±0.13 0.56±0.18 0.7±0.24 
Values were expressed as mean± S.D. for N=10 rats in each group one-way ANOVA 
followed by Dunnett’s test. Significant indicates  *P<0.05,**P<0.01 
 
Effect of Palagarai chunnam on Renal Parameters-–Figure 13 
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28 Day Repeated Dose Oral Toxicity Study 
 
The results of the liver function test conducted at the end of the study, test 
groups revealed significant changes in levels of liver parameters, when compared 
with control group. 
Table:15 Effect of Palagarai chunnam on Hepatic Parameters 
 
 CONTROL LD MD HD 
Total Bilirubin 
(mg/dl) 
0.32±0.12 0.37±0.11 0.34±0.15 0.53±0.38 
SGOT (IU/ml) 89±10.82 92.9±17.95 97.4±32.3 97.5±16.15 
SGPT (IU/ml) 26.4±7.27 30.8±7.10 36.8±6.97** 36.8±7.05** 
Values were expressed as mean± S.D. for N=10 rats in each group one-way 
ANOVA followed by Dunnett’s test. Significant indicates *P<0.05,**P<0.01 
               
                  Effect of Palagarai chunnam on Hepatic Parameters-–Figure 14 
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             Effect of Palagarai chunnam on Hepatic Parameters-–Figure 15 
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28 Day Repeated Dose Oral Toxicity Study 
 
Histopathology of Heart 
              
Control –Male                                                             Control- Female 
                                  
 
 
High dose-Male                                                          High dose- Female 
                                  
 
 
 
Control Male        : Sarcoplasmic region of myocardium appears normal 
Control Female     : Endocardium appears normal with no evidence of necrosis 
High dose Male     :Appearance of fibrils and cross striations are equidistant 
High dose Female : No evidence of atherosclerosis and thrombosis ,No evidence of 
necrotic myocardium 
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       2.Lungs 
 
Control-Male                                                      Control-Female                 
                              
 
Highdose-Male                                                   High dose-Female 
                              
 
 
 
 
Control Male      : Bronchial opening appears regular with no signs of infiltration 
Control Female : Lung parenchyma appears normal with regular arrangement of alveoli 
and alveolar sac with no signs of lymphocyte infiltration and pulmonary fibrosis 
High dose Male  : Perfect network of simple squamous epithelium were observed 
High dose Female: Appearance of alveolar network was normal 
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                                                       3. Brain 
 
Control-Male                                                             Control- Female 
                                      
   
 
High dose- Male                                                       High dose-Female  
                                     
 
 
 
 
Control Male    : Showed normal architecture in both cortex and medulla where three 
layers of cerebellar cortex 
Control Female    : Appearance of Hippocampal neurons was normal with dense network  
High dose Male    : Regular marginal alignment on the neurons with promising histology 
were observed 
High dose Female: Normal neural architecture with No signs of vascular congestion and 
edema 
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                                                          3. Stomach 
 
Control-Male                                                               Control- Female 
                                       
                                                                                 
High dose-Male                                                            High dose-Female   
                                       
 
 
 
 
 
Control Male   : Regular histology of Inner circular muscle (ICM), gastric pit (GP), and 
muscularis mucosae (MM) were observed. 
Control Female: Gastric glands, gastric glands including secretary sheath appears normal  
High dose Male: The continuity of mucosa was normal with no evidence of ulceration 
High dose Female: Normal gastric mucosa containing intact gastric glands and parietal 
cells 
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                                4. Spleen 
Control-Male                                                            Control-Female 
                                    
High dose-Male                             High dose-Female 
                                     
 
Control Male     : The appearance of red pulp and marginal sinus are normal. No 
abnormalities found in lymph nodes 
Control  Female: Marginal sinus (MS) of the spleen and its sinus lining cells appears 
normal 
High dose Male: Mild changes were observed in spleen architecture with increased number 
of megakaryocytes. 
High dose Female: Appearance of splenic red pulp was normal,No signs of perivascular 
inflammation. 
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5. Liver  
Control-Male                                      Control-Female 
                                             
High Dose-Male                High dose-Female
                
 
 
Control Male: No evidence of collagen (fibrosis) increased numbers of kupffer cells were 
observed and increase in sinusoidal spaces were observed 
Control Female: Distinct widen hepatic cords that were dorsally radiating from the central 
vein were observed. Occasional appearances of foamy cytoplasm were observed. 
High Dose Male: Liver sinusoid appears widen with occasional bi nucleated hepatocytes 
High dose Female: Derangement of hepatic parenchyma with mild congestion of central 
vein were observed. 
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         6.Kidney 
Control –Male                 Control-Female  
                                     
High dose- Male                 High dose-Female 
    
 
 
Control Male    : Appearance of glomerular basement membrane was normal, lumen of 
vessels and bowman’s space appears normal 
Control Female   : Section projecting the evidence of tubular protein cast. 
High dose  Male  : Arrangement of glomerular loop was normal with regular interstitium 
High dose Female: No evidence of interstitial inflammation and lymphocyte accumulation 
The dilated tubules are lined by flattened epithelium and their lumen 
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         7. Testis 
 
Control- Male                                 High dose -Male 
                       
 
 
 
 
 
 
 
 
 
 
 
 
Control Male       : Histo cytology of testicular tissue shows well differentiated germ cells 
 
High dose Male  : Appearance of leydig cells, interstitial tissue , seminiferous tubule, 
Sertoli cells and spermatogonia were normal. 
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          8. Uterus 
Control-Female                      High dose- Female  
                         
 
 
 
Control Female      : Endometrial gland, epithelium and blood vessels appears normal 
High dose  Female : Arrangement of stratum basale, functionale and surface epithelium 
seems normal 
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       9. Ovary 
Control-Female                    High dose-Female 
                                   
 
 
 
 
Control Female      : Corpora lutea (CL), atretic follicles (AF) and interstitial tissue (IT) 
appears normal 
  
High dose Female : Sequential arrangement of granulosa cells around oocyte was 
normal and regular 
 
. 
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             6. DISCUSSION 
 
Metals and minerals are held in hand to hand in Siddha Pharmaceuticals with 
suitable as well as various process of purification. Since Palagarai obtained from sea, is 
believed to contain a large number of essential minerals in it. Therefore it has to be purified 
before using in the medicine preparation. In Siddha  system  of  medicine one of the 
farfetched drug is palagarai, it has a long history in the treatment of many diseases among 
Siddha physicians.  
Palagarai is used in many area of medicine, it plays vital role in siddha medicinal 
practice. The usage of palagarai mentioned in siddha literature has to be reviewed. The 
Medicinal preparation from palagarai are mostly Parpam, Chenduram, Chunnam. Palagarai 
Parpam is indicated as an antidote to various to types of poisons of animals and other living 
creatures. Therefore, exploration about this natural resource drug at this time will be 
economically beneficial as huge amount of fund has been required to develop a synthetic 
antidote from poison itself.35
 
Palagarai chunnam is one of the traditional Siddha formulation which is indicated as 
a best drug for Female Infertility, Dysmenorrhea, Anemia, Dropsy in Siddha text
33
. As an 
initial step, in this present study, a part of standardization of this drug and its safety has been 
confirmed through  necessary analysis  and  Acute  & 28  days  Repeated  Oral  Toxicity 
studies as per OECD guidelines.
36,37
 
Standardization of the drugs means confirmation of its identity and determination  of 
its quality and purity
38
. Standardization of the chunnam was confirmed by the methodology 
of the siddha text. 
             Physiochemical analysis of the palagarai chunnam From Table 1, shows that The 
Organoleptic characters shows that Palagarai chunnam is dull white in color and odorless 
powder form of drug with pH of 7.87%. reveals that, this is a slightly alkaline which is 
expected to have significant absorption in the in the stomach than in intestine.  The loss on 
drying is less than 1% w/w, which explains its moisture content of test drug is very low. 
Loss on drying is loss of weight expressed as in percentage w/w resulting from water and 
volatile matter of any kind that can be driven off under specific condition
39
.  It is easily 
soluble in water, alcohol and acetone and ether. 
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  Ash values are helpful in determining the quality and purity of crude drugs, 
especially in powder form
40
. Total ash value is 97.01%, it implies that presence of 
inorganic constituents. Acid insoluble ash is 34.69%, and Water soluble ash is16.96%. 
This explains the purity of the test drug. 
  Qualitative analysis (Tables-3,4,5) of palagarai chunnam for Acid radicals, Basic 
radicals, and other constituents demonstrates the presence of Carbonate, Aluminum , Iron, 
zinc, calcium and alkaloids. 
The Inductively Coupled Plasma Optical Emission Spectrometry(ICP-OES) 
analysis palagarai chunnam showed that the presence of physiologically important minerals 
like Iron, Calcium, Aluminum, Zinc and Magnesium. Heavy metals such as Mercury, Lead, 
Arsenic and Cadmium were found below the detectable limit. 
The presence Zinc which is required for wound healing property
41 
found in Palagarai 
may aid as topical application as an ointment for different kind of wounds also It is the 
second most abundant trace metal in humans after iron and it is the only metal which 
appears in all enzyme classes
42
 and Zinc plays major role in the Reproductive organ 
developments, ripe for fertilization. Iron and calcium are the major element in human body 
manage the various biological activity. 
The Fourier Transform Infra Red Spectroscopy (FTIR) analysis of Palagarai 
chunnam shows the presence of vibrational band observation around ~ 1420 to 1500 cm
-1
 
and 860 to 875 cm
-1
 confirms is attributed to the presence of calcium carbonate 
43
. 
The morphology of the Palagarai chunnam drug can be determined by SEM.    The 
photographs shows that particles are spherical in shapes and sizes are in the range from         
1 to 3 μm. Thus, the size of the particle is capable to encourage the efficacy. 
In Acute toxicity study (Table -7), carried out as per OECD guideline 423, there 
was no treatment-related death or signs of toxicity developed in albino rats at dosage levels 
of 300mg and 2000mg/kg body weight throughout the study period. Further, no gross 
pathological changes have been seen in the internal organs of both control and treated 
groups. This study reveals the Safety of the drug. 
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To confirm the safety of Palagarai chunnam, 28 days Repeated Oral Toxicity Study 
was also carried out as per OECD test guideline 407. The animals were grouped and treated 
with different doses in study period as per guidelines. After 28 days blood collection done 
for animals of all groups. All the animals were euthanized for gross pathological 
examinations of all major internal organs. The blood samples were sent to a lab for 
hematological and biochemical analysis.  The organs were weighed and preserved in 10% 
buffered formalin solution before sending for Histopathological study. All the reports were 
statistically evaluated. 
 Palagarai chunnam Substantial difference in Food and water intake the test group 
animals were observed when compared with control group during the study period(Table8,9 
& Figure4,5) but they are within physiological limit, and this study exposes that it does not 
undesirably affect the basic metabolic processes of the experimental animals. In 
Hematological parameters, it had been observed that hemoglobin level was elevated after the 
administration of palagarai chunnam at the high dose level when it compared to control 
group animal(Table 12 & Figure 10). But the Hb level was gradually increased in test group 
compared to the control group but within normal range. In test groups there was significant 
changes present in Lipid profile, when compared with the control group. At the values were 
normal biological limits. ( Table 13, Figure 12). 
The Bio chemical parameters like Renal and hepatic parameters has significant 
changes but within normal range.(Table 14,15& Figure 13,14,15). The Histopathological 
study, organs such as brain, heart, kidney, liver, lungs, spleen and stomach were taken. In 
organs of Control and test group, no abnormality was detected. There’s no pathological 
changes occur in all group of animals during the study period. 
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7. SUMMARY 
 
Palagarai chunnam is one of the traditional Siddha formulation which is indicated as a 
best drug for Female Infertility, Dysmenorrhea, Anemia, Dropsy in Siddha text Scientific 
validation of this formulation Palagarai chunnam  have to be studied and the safety of the drug 
have to be ensured. The raw drug was procured from raw drug store. They were identified and 
authenticated by Zoological survey of India and Herbal plants were authenticated from Botanist, 
National Institute of Siddha. The Raw drugs were purified and the medicine was prepared as 
mentioned in the Siddha literature.  On organoleptic examination, the finished product seems to 
be dull white in color and powder in nature. 
The test drug was evaluated with Qualitative and Quantitative analysis to assess safety by 
acute and subacute toxicity studies. Standardization of the chunnam was confirmed by the 
methodology of the siddha text. 
 Total Ash value, Acid insoluble Ash value, Water, and Alcohol Soluble Extractive 
values reveal the purity of the test drug. Qualitative Analysis of test drug demonstrates the 
presence of Calcium, Iron, zinc, Aluminium and Alkaloids.   
SEM results confirm the presence of micro-sized, spherical shaped particles ranging 
between 1 to 3µm, with a smooth surface in evenly distribution. ICP-OES analysis palagarai 
chunnam showed that the presence of physiologically important minerals like Iron, Calcium, 
Aluminum, Zinc and Magnesium. 
 
The toxicological evaluations were conducted as per OECD guidelines   423 & 407 for 
safety evaluation of test drug. In acute toxicity study, no signs of toxicity and mortality were 
observed throughout the study period up to the dose of 2000mg/kg body weight but there is no 
abnormality was noted. In 28days Repeated dose Oral Toxicity Study, there was no significant 
changes in behavioral signs,  food intake,  water intake,  Lipid Profile, Renal parameters 
hematological parameters and Hepatic parameters. In histological study of vital organs of Control 
group and high dose drug treated  groups shows  no abnormality. These findings were desire the 
safety of Palagarai chunnam used in Siddha system of medicines. 
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8. CONCLUSION 
This study results that the Qualitative analysis of Palagarai chunnam reveals the Purity 
and Bioavailability of the drug Quantitative analysis expound the presence of essential trace 
elements in test drug which is import for various imperative biological activity for human body. 
In vivo toxicity studies indicate that there was no mortality and signs of toxicity observed for 
acute oral administration of test drug till the dose 2000 mg/kg b.wt in the recommended 
manner. In 28 days repeated oral toxicity study hematological and biochemical parameters are 
normal limits and no significant abnormality present in internal organs. Based on these results 
it can be conclude that, the dose level of kundri alavu (130mg) mentioned in Siddha 
maruthuva nool thirattu - Anubhava Siddha Vaithiya Muraigal is safety dose for human 
consumption. 
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   10. ANNEXURE  
The following certificates are enclosed  
 1. Research Methodology and Biostatistics 
 2. Basic Research techniques and practices involved in Laboratory Animal care 
 3. IAEC Certificate for Acute and Sub Acute toxicity study 
 4. Authentication Certificate for herbal Plants  
 5. Authentication Certificate for marine drug ( Palagarai)  
 
 





